MATERNAL-FETAL TOLERANCE IS MAINTAINED DESPITE TRANSGENE-DRIVEN TROPHOBLAST EXPRESSION OF MHC CLASS-I, AND DEFECTS IN FAS AND ITS LIGAND

Citation
Am. Rogers et al., MATERNAL-FETAL TOLERANCE IS MAINTAINED DESPITE TRANSGENE-DRIVEN TROPHOBLAST EXPRESSION OF MHC CLASS-I, AND DEFECTS IN FAS AND ITS LIGAND, European Journal of Immunology, 28(11), 1998, pp. 3479-3487
Citations number
32
Categorie Soggetti
Immunology
ISSN journal
00142980
Volume
28
Issue
11
Year of publication
1998
Pages
3479 - 3487
Database
ISI
SICI code
0014-2980(1998)28:11<3479:MTIMDT>2.0.ZU;2-3
Abstract
During mammalian pregnancy, one or more semiallogeneic fetuses gestate in direct contact with the maternal circulation and uterine tissue. H owever, a damaging maternal immune response is not normally provoked. We studied two possible mechanisms for this maternal-fetal tolerance, alone and in combination. First, we directly tested the hypothesis tha t the striking absence of MHC class I molecules on most placenta troph oblasts protects the fetus from maternal immune attack, by creating tr ansgenic mice which express L-d in giant cell trophoblasts. Second, be cause Pas ligand (FasL) may contribute to immune privilege, we tested whether functional Fast expression by the fetus, or Pas expression by the mother, contributes to successful reproduction in a fully allogene ic breeding. Our data indicate that neither abnormal expression of MHC class I in giant cells, nor disruption of the Fas-FasL system, nor a combination of these two defects, has an adverse effect on pregnancy o utcome. These results suggest that during healthy allogeneic: pregnanc y, down-regulation of MHC class I and expression of Fast on placenta a re not critical events, and other factors must prevent a harmful mater nal immune response.